MedImmune

AstraZeneca appoints new U.S. chief? 1 hr ago

pharmiweb.co.uk
15 hrs ago 13 related
        

LONDON, Nov 18 (Reuters) - AstraZeneca, the Anglo/Swedish drugmaker, announced on Tuesday the appointment of Rich Fante as the new president of itsU.S. operation. Fante, who has been with the company for 13 years, takes over...

add comment
                   

Learn about the World Biotechnology Market Brief (Business Wire)

yahoo.com
20 hrs ago 17 related
        

Tuesday November 18, 8:27 am ET NEW YORK--(BUSINESS WIRE)--Reportlinker.com announces that a new market research report related to the Biotechnologies and Genetics industry is available in its catalogue. Market (2003):...

add comment

Recipharm Enters Into Partnership With Astrazeneca For Swedish Biomanufacturing Facility

pharmiweb.co.uk
yesterday
        

AstraZeneca has announced the divestment of the AstraZeneca Biotech Laboratory (ABL) in Södertälje, Sweden, to Recipharm AB of Sweden, a leading contract development and manufacturing organization. Under the terms of the...

add comment
                   

MedImmune Announces Winners of Third Annual Research Abstract Competition

finanznachrichten.de
yesterday 4 related
        

GAITHERSBURG, Md., Nov. 17 /PRNewswire/ -- Last Friday, MedImmune convened the competition's 10 finalists to present their research to an expert panel of MedImmune judges in the Third Annual Research Abstract Competition at the...

add comment

Biota Holdings Limited (ASX:BTA) LANI Phase III Clinical Trials Set For Enrolment

yahoo.com
17-Nov-2008 2 related
        

Melbourne, Australia, Nov 17, 2008 - (ABN Newswire) - Biota Holdings Limited (ASX:BTA)(PINK:BTAHY) today announced that the multiple centres involved in the Phase III clinical trail on its long acting neuraminidase inhibitor...

add comment
                   

Genaera Corporation Announces Third Quarter Financial Results

finanznachrichten.de
14-Nov-2008 3 related
        

PLYMOUTH MEETING, Pa., Nov. 14 /PRNewswire-FirstCall/ -- Genaera Corporation today announced its financial results for the three- and nine-month periods ended September 30, 2008. The net loss for the three-month period ended...

add comment
                   

Gravy or Turkey From the FDA?

msn.com
14-Nov-2008 3 related
        

These drugmakers should be made aware of their fate over the next few weeks. It's the binary news events -- clinical trial results and Food and Drug Administration approvals -- that make drug developers so fun to invest in, and...

add comment

Conformia Biotech Working Group to Convene in Washington, DC

finanznachrichten.de
14-Nov-2008
        

Senior thought leaders from seven of the major biotech and pharmaceutical companies will convene in Washington, DC next week to discuss future drug development paradigms in light of the new ICH Quality Vision. Specifically,...

add comment
genengnews.com: Genetic Engineering genengnews.com

AstraZeneca insider Zook to lead biotech unit

pharmiweb.co.uk
13-Nov-2008 7 related
        

LONDON, Nov 13 (Reuters) - AstraZeneca (AZN.L: ) has appointed insider Tony Zook as president of MedImmune, its biotechnology unit, the Anglo-Swedish company said on Thursday. Zook had already been heading the operation on an...

add comment
                   

Micromet to Present Interim Data from Two Studies for T Cell Engaging BiTE Antibody Blinatumomab...

finanznachrichten.de
13-Nov-2008 5 related
        

BETHESDA, Md., Nov. 13 /PRNewswire-FirstCall/ -- Micromet, Inc. , a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that two...

add comment
1 2 3 4 5 next »